APYX MEDICAL CORPORATION

Analyst Reco. Apyx Medical Corporation

Equities

APYX

US03837C1062

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
1.45 ^USD	-2.03%		+9.85%	-44.66%

04-05	Archon Capital Management Engages with Apyx Medical Corporation	CI
04-01	Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stephens Adjusts Price Target on Apyx Medical to $5 From $8, Keeps Overweight Rating	11-10	MT
Stephens Initiates Apyx Medical With Overweight Rating, $8 Price Target	23-07-14	MT
Lake Street Raises Apyx Medical's Price Target to $9 From $6, Maintains Buy Rating	23-06-15	MT
Lake Street Adjusts Price Target on Apyx Medical to $6 From $5, Keeps Buy Rating	23-05-12	MT
Lake Street Assumes Apyx Medical at Buy Rating With $5 Price Target	22-12-08	MT
Piper Sandler Adjusts Price Target on Apyx Medical to $12 From $6, Reiterates Overweight Rating	22-08-12	MT
Lake Street Raises Apyx Medical's Price Target to $17 From $14, Maintains Buy Rating	22-07-19	MT
Lake Streets Initiates Apyx Medical at Buy, Sets Price Target at $12	22-05-20	MT
Piper Sandler Adjusts Apyx Medical's Price Target to $6 From $12, Reiterates Overweight Rating	22-05-13	MT
Piper Sandler Lowers Price Target for Apyx Medical to $12 From $20, Maintains Overweight Rating	22-03-17	MT
APYX MEDICAL : JMP Securities Adjusts Price Target on Apyx Medical to $14 From $12, Maintains Market Outperform Rating	21-08-13	MT
APYX MEDICAL : Piper Sandler Adjusts Apyx Medical PT to $12 From $8, Maintains Overweight Rating	21-01-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer